Cambodia vs Rwanda: Cause of death, by non-communicable diseases, ages 60+, male
Cambodia
69.3%
in 2021
Rwanda
69.0%
in 2021
Cambodia rank
89th
Rwanda rank
92nd
Cause of death, by non-communicable diseases, ages 60+, male over time
- Cambodia
- Rwanda
How they compare
Cambodia currently reports 69.3% against 69.0% in Rwanda, a difference of 0.3%.
Across all 6 years both countries report, Cambodia has been ahead every year.
Cambodia ranks 89th and Rwanda ranks 92nd of 185 countries.
Cambodia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.2% | 69.8% | 1.4% | Cambodia |
| 2010s | 77.7% | 72.4% | 5.3% | Cambodia |
| 2020s | 74.5% | 71.4% | 3.0% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Cambodia or Rwanda?
- Cambodia, at 69.3% against 69.0% in Rwanda as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Cambodia and Rwanda?
- 0.3%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Rwanda?
- 6 years are reported by both, from 2000 to 2021.
- How do Cambodia and Rwanda rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Cambodia ranks 89th and Rwanda ranks 92nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.